Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care

Journal of General Internal Medicine

Volumn 32, Issue 9, 2017, Pages 990-996

  Gryczynski, Jan ^a   McNeely, Jennifer ^b   Wu, Li Tzy ^c   Subramaniam, Geetha A ^d   Svikis, Dace S ^e   Cathers, Lauretta A ^e   Sharma, Gaurav ^f   King, Jacqueline ^f   Jelstrom, Eve ^f   Nordeck, Courtney D ^a   Sharma, Anjalee ^a   Mitchell, Shannon G ^a   O’Grady, Kevin E ^g   Schwartz, Robert P ^a  

^a FRIENDS RESEARCH INSTITUTE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^f EMMES CORPORATION   (United States)

^g UNIVERSITY OF MARYLAND   (United States)

Author keywords

primary care; screening; substance use disorders; unhealthy substance use

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ALCOHOL; AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; BENZOYLECGONINE; BIOLOGICAL MARKER; CANNABIS; COCAINE; CODEINE; DIAMORPHINE; HYDROCODONE; ILLICIT DRUG; METHADONE; METHAMPHETAMINE; MIDOMAFETAMINE; MORPHINE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; OPIATE; OXYCODONE; PHENCYCLIDINE; PRESCRIPTION DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BEHAVIOR DISORDER ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG MISUSE; DRUG USE; DSM-5; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORAL BIOPSY; PREVALENCE; PRIMARY MEDICAL CARE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SUBSTANCE USE; TOBACCO; TOBACCO USE; TOBACCO, ALCOHOL, PRESCRIPTION MEDICATION, AND OTHER SUBSTANCE USE TOOL; VALIDATION PROCESS; CLASSIFICATION; DRINKING BEHAVIOR; INTERPERSONAL COMMUNICATION; MASS SCREENING; PRIMARY HEALTH CARE; PROCEDURES; QUESTIONNAIRE; STANDARDS; STATISTICS AND NUMERICAL DATA; VALIDATION STUDY;

ADULT; ALCOHOL DRINKING; DISCLOSURE; DRUG USERS; FEMALE; HUMANS; MASS SCREENING; PRIMARY HEALTH CARE; SUBSTANCE-RELATED DISORDERS; SURVEYS AND QUESTIONNAIRES; TOBACCO PRODUCTS;

EID: 85019770501     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-017-4079-x     Document Type: Article

References (32)

1. Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000–2004. Morb Mortal Wkly Rep. 2008;57(45):1226–28.
2. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373:2223–33.
3. Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1564–74.
4. Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379:55–70.
5. Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12:657–67.
6. McLellan AT, Woodworth AM. The Affordable Care Act and treatment for "substance use disorders:" implications of ending segregated behavioral healthcare. J Subst Abuse Treat. 2014;46:541–5.
7. Buck JA. The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Aff. 2011;30:1402–10.
8. Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med. 2010;170:1155–60.
9. U.S. Preventive Services Task Force. Final recommendation statement: tobacco smoking cessation in adults, including pregnant women: behavioral and pharmacotherapy interventions. 2015. Available at: http://www.uspreventiveservicestaskforce.org/page/document/recommendationstatementfinal/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions. Accessed 12 April 2017.
10. Moyer VA. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: U.S. preventive services task force recommendation statement. Ann Intern Med. 2013;159:210–8.
11. Bernstein J, Bernstein E, Tassiopoulos K, Heeren T, Levenson S, Hingson R. Brief motivational intervention at a clinic visit reduces cocaine and heroin use. Drug Alcohol Depend. 2005;77:49–59.
12. Humeniuk R, Ali R, Babor T, et al. A randomized controlled trial of a brief intervention for illicit drugs linked to the alcohol, smoking and substance involvement screening test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction. 2012;107:957–66.
13. Gelberg L, Andersen RM, Afifi AA, et al. Project QUIT (Quit Using Drugs Intervention Trial): a randomized controlled trial of a primary care-based multi-component brief intervention to reduce risky drug use. Addiction. 2015;110:1777–90.
14. Roy-Byrne P, Bumgardner K, Krupski A, et al. Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial. JAMA. 2014;312:492–501.
15. Saitz R, Cheng DM, Allensworth-Davies D, Winter MR, Smith PC. The ability of single screening questions for unhealthy alcohol and other drug use to identify substance dependence in primary care. J Stud Alcohol Drugs. 2014;75:153–7.
16. Dart RC, Severtson SG, Bucher-Bartelson B. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372:1573–4.
17. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths—United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2016;64:1378–82.
18. Pilowsky DJ, Wu LT. Screening for alcohol and drug use disorders among adults in primary care: a review. Subst Abuse Rehabil. 2012;3:25–34.
19. Humeniuk R, Ali R, Babor TF, et al. Validation of the alcohol, smoking and substance involvement screening test (ASSIST). Addiction. 2008;103:1039–47.
20. McNeely J, Cleland CM, Strauss SM, Palamar JJ, Rotrosen J, Saitz R. Validation of self-administered single-item screening questions (SISQs) for unhealthy alcohol and drug use in primary care patients. J Gen Intern Med. 2015;30:1757–64.
21. Tiet QQ, Leyva YE, Moos RH, Frayne SM, Osterberg L, Smith B. Screen of drug use: diagnostic accuracy of a new brief tool for primary care. JAMA Intern Med. 2015;175:1371–7.
22. Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Intern Med. 2009;24:783–8.
23. Arroll B, Goodyear-Smith F, Crengle S, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. 2010;8:348–53.
24. National Institute on Drug Abuse (NIDA). Resource guide: screening for drug use in general medical settings. 2016. Available at: https://www.drugabuse.gov/publications/resource-guide-screening-drug-use-in-general-medical-settings/nida-quick-screen. Accessed 12 April 2017.
25. Ali R, Meena S, Eastwood B, Richards I, Marsden J. Ultra-rapid screening for substance-use disorders: the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST-Lite). Drug Alcohol Depend. 2013;132:352–61.
26. McNeely J, Wu LT, Subramaniam G, et al. Performance of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool for substance use screening in primary care patients. Ann Intern Med. 2016;165(10):690–699.
27. Wu LT, McNeely J, Subramaniam GA, Sharma G, VanVeldhuisen P, Schwartz RP. Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool. Contemp Clin Trials. 2016;50:90–97.
28. World Health Organization. The World Mental Health Composite International Diagnostic Interview. 2015. Available at: http://www.hcp.med.harvard.edu/wmhcidi/index.php. Accessed 12 April 2017.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 2013. Available at: https://www.psychiatry.org/psychiatrists/practice/dsm/dsm-5. Accessed 12 April 2017.
30. Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse. Clin Chem. 2009;55(11):1910–1931.
31. Perkins NJ, Schisterman EF. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163:670–5.
32. Butler SF, Villapiano A, Malinow A. The effect of computer-mediated administration on self-disclosure of problems on the addiction severity index. J Addict Med. 2009;3:194–203.